FOI 2840 2022/23
The incidence and treatment of fungal infections in the UK
Published 21 September 2023
The incidence and treatment of fungal infections in the UK
Questions
Q1. In the last 12 months, how many patients have been treated (for any condition) with the following drugs?
Amphotericin B (Ambisome)
Caspofungin (Cancidas)
Isavuconazole (Cresemba)
Posaconazole (Noxafil)
Voriconazole (VFEND)
Q2a. In the last 12 months, how many hospital inpatients were diagnosed with Aspergillosis (ICD10 code: B44)?
Q2b. Of the above patients diagnosed with Aspergillosis in the last 12 months, how many patients were treated with the following drugs:
Amphotericin B (Ambisome)
Caspofungin (Cancidas)
Isavuconazole (Cresemba)
Posaconazole (Noxafil)
Voriconazole (VFEND)
Q3a. In the last 12 months, how many hospital inpatients were diagnosed with Mucormycosis (ICD10 code: B46)?
Q3b. Of the above patients diagnosed with Mucormycosis in the last 12 months, how many patients were treated with the following drugs:
Amphotericin B (Ambisome)
Isavuconazole (Cresemba)
Posaconazole (Noxafil)
Response
Q1.
|
Drug |
Number_of_patients |
|
Isavuconazole (Cresemba) |
19 |
|
Posaconazole (Noxafil) |
138 |
|
Voriconazole (VFEND) |
159 |
|
Amphotericin B (Ambisome) |
205 |
|
Caspofungin (Cancidas) |
34 |
Q2a.
114
Q2b.
|
Drug |
Number_of_patients |
|
Isavuconazole (Cresemba) |
0 |
|
Posaconazole (Noxafil) |
7 |
|
Voriconazole (VFEND) |
21 |
|
Amphotericin B (Ambisome) |
4 |
|
Caspofungin (Cancidas) |
3 |
Q3a.
3
Q3b.
|
Drug |
Number_of_patients |
|
Isavuconazole (Cresemba) |
1 |
|
Posaconazole (Noxafil) |
1 |
|
Amphotericin B (Ambisome) |
1 |